Anteris Technologies Ltd (AVR.AX)
| Previous close | 21.30 |
| Open | 21.70 |
| Bid | 21.29 x 60900 |
| Ask | 21.60 x 237300 |
| Day's range | 21.16 - 21.70 |
| 52-week range | 15.58 - 24.38 |
| Volume | |
| Avg. volume | 17,167 |
| Market cap | 408.987M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023
BRISBANE, Australia & MINNEAPOLIS, September 12, 2023--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing the world’s only balloon-expandable, single-piece transcatheter aortic valve (TAVR) for the treatment of aortic stenosis announced today that Wayne Paterson, the Chief Executive Officer of Anteris will present at the Cantor Fitzgerald Annual Global Healthcare Conference in New York, NY on Tuesday, September 26, 2023, at 2:45 p.m. Eastern Time.
- Business Wire
DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case
BRISBANE, Australia & MINNEAPOLIS, August 14, 2023--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve was implanted in a second successful Valve-in-Valve (ViV) procedure as part of Health Canada’s Special Access Program (SAP).
- Business Wire
Anteris Technologies Commences American Depository Receipt Program
BRISBANE, Australia & MINNEAPOLIS, August 09, 2023--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that it has established a sponsored Level 1 American Depository Receipt (ADR) program in the United States. The ADR program has been set up to improve U.S. investor access to Anteris ordinary shares.
